Current Vascular Pharmacology
Title: Editorial [ The Metabolic Syndrome: Revisiting the Concept, the Diagnosis and the Treatment (Part-I)Guest Editors: John H. McNeill and Vijay Sharma ]
Volume: 4 Issue: 3
Author(s): John H. McNeill
Affiliation:
Export Options
About this article
Cite this article as:
McNeill H. John, Editorial [ The Metabolic Syndrome: Revisiting the Concept, the Diagnosis and the Treatment (Part-I)Guest Editors: John H. McNeill and Vijay Sharma ], Current Vascular Pharmacology 2006; 4 (3) . https://dx.doi.org/10.2174/157016106777698405
DOI https://dx.doi.org/10.2174/157016106777698405 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preface [Hot Topic: Molecular and Cellular Mechanisms of Ischemic Cell Death in the Brain (Executive Editor: Rita Sattler)]
Current Molecular Medicine Chinese Herbal Medicine Interventions in Neurological Disorder Therapeutics by Regulating Glutamate Signaling
Current Neuropharmacology Evaluating Protein-protein Interaction (PPI) Networks for Diseases Pathway, Target Discovery, and Drug-design Using `In silico Pharmacology`
Current Protein & Peptide Science Bone Mineral Density Assessment by DXA vs. QCT in Postmenopausal Females with Central Obesity
Current Aging Science Regional Cerebral Blood Flow and Cerebrovascular Reactivity in Alzheimer’s Disease and Vascular Dementia Assessed by Arterial Spinlabeling Magnetic Resonance Imaging
Current Neurovascular Research Pidotimod and Immunological Activation in Individuals Infected with HIV
Current HIV Research Kinins and Cardiovascular Diseases
Current Pharmaceutical Design Organoselenium Small Molecules and Chromium(III) Complexes for Intervention in Chronic Low-grade Inflammation and Type 2 Diabetes
Current Topics in Medicinal Chemistry Effect of a New Class of Compounds of the Group of Substituted 5R1, 6H2-1,3,4-thiadiazine-2-amines on the Inflammatory and Cytokine Response in Experimental Myocardial Infarction
Current Vascular Pharmacology Editorial (Thematic Issue: Crosstalk Between the Nervous and the Immune Systems in Health and Sickness)
Current Pharmaceutical Design Globalization of Clinical Trials – Where are We Heading?
Current Clinical Pharmacology Biochemical Differentiation of Cholinesterases from Normal and Alzheimers Disease Cortex
Current Alzheimer Research Prevention of Cell Damage in Ischaemic-Reperfusion: Mitochondrial Respiratory Chain as a Pharmacological Target
Letters in Drug Design & Discovery Endothelial Dysfunction, Obesity and Insulin Resistance
Current Vascular Pharmacology Cyclooxygenase-2 in Synaptic Signaling
Current Pharmaceutical Design Multi-Pharmacophore Modeling of Caspase-3 Inhibitors using Crystal, Dock and Flexible Conformation Schemes
Combinatorial Chemistry & High Throughput Screening Novel Antidiabetic Agents: Cardiovascular and Safety Outcomes
Current Pharmaceutical Design Crosstalk between Inflammation and Coagulation: The Lessons of Sepsis
Current Vascular Pharmacology Fatty Acids Recommendations: Controversies and Updates
Current Nutrition & Food Science Human Embryonic Stem Cell-Derived Cardiomyocytes for Heart Therapies
Cardiovascular & Hematological Disorders-Drug Targets